Coral Gables, FL2 Active Studies

Advanced Solid Tumors Clinical Trials in Coral Gables, FL

Find 2 actively recruiting advanced solid tumors clinical trials in Coral Gables, FL. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
330
Enrolling

Recruiting Advanced Solid Tumors Studies in Coral Gables

About Advanced Solid Tumors Clinical Trials in Coral Gables

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 2 advanced solid tumors clinical trials recruiting participants in Coral Gables, FL. These studies are seeking a combined 330 participants. Research is being sponsored by SillaJen, Inc., National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in Coral Gables — FAQ

Are there advanced solid tumors clinical trials in Coral Gables?

Yes, there are 2 advanced solid tumors clinical trials currently recruiting in Coral Gables, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Coral Gables?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Coral Gables research site will contact you about next steps.

Are clinical trials in Coral Gables free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Coral Gables studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 2 active trials in Coral Gables are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated July 13, 2026 from ClinicalTrials.gov